Dimensional Fund Advisors’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$405K Buy
239,906
+99,849
+71% +$206K ﹤0.01% 2973
2025
Q4
$277K Buy
+140,057
New +$448K ﹤0.01% 3054
2024
Q2
Sell
-29,656
Closed -$602K 3401
2024
Q1
$602K Buy
29,656
+12,319
+71% +$284K ﹤0.01% 3010
2023
Q4
$390K Buy
+17,337
New +$366K ﹤0.01% 3082
2022
Q4
Sell
-6,227
Closed -$260K 3514
2022
Q3
$260K Buy
+6,227
New +$168K ﹤0.01% 3192
2021
Q4
Sell
-3,856
Closed -$239K 3554
2021
Q3
$239K Sell
3,856
-22,504
-85% -$1.88M ﹤0.01% 3317
2021
Q2
$2.25M Sell
26,360
-227
-0.9% -$12.2K ﹤0.01% 2838
2021
Q1
$1.19M Sell
26,587
-2,163
-8% -$85.1K ﹤0.01% 2979
2020
Q4
$196K Hold
28,750
﹤0.01% 3224
2020
Q3
$331K Hold
28,750
﹤0.01% 3135
2020
Q2
$89K Buy
28,750
+15,564
+118% +$70.6K ﹤0.01% 3284
2020
Q1
$54K Buy
+13,186
New +$87.3K ﹤0.01% 3315
2018
Q3
Sell
-59,989
Closed -$124K 3435
2018
Q2
$124K Hold
59,989
﹤0.01% 3286
2018
Q1
$425K Hold
59,989
﹤0.01% 3131
2017
Q4
$240K Hold
59,989
﹤0.01% 3198
2017
Q3
$244K Hold
59,989
﹤0.01% 3198
2017
Q2
$247K Buy
+59,989
New +$283K ﹤0.01% 3181
2016
Q4
Sell
-89,775
Closed -$628K 3300
2016
Q3
$628K Sell
89,775
-5,336
-6% -$88.4K ﹤0.01% 3024
2016
Q2
$1.46M Hold
95,111
﹤0.01% 2848
2016
Q1
$1.49M Hold
95,111
﹤0.01% 2837
2015
Q4
$1.17M Sell
95,111
-5,958
-6% -$78.8K ﹤0.01% 2929
2015
Q3
$1.29M Sell
101,069
-2,063
-2% -$26K ﹤0.01% 2937
2015
Q2
$1.25M Sell
103,132
-6,965
-6% -$95.4K ﹤0.01% 2970
2015
Q1
$1.46M Hold
110,097
﹤0.01% 2898
2014
Q4
$1.56M Sell
110,097
-902
-0.8% -$15.6K ﹤0.01% 2902
2014
Q3
$3.04M Buy
110,999
+2,142
+2% +$65.1K ﹤0.01% 2714
2014
Q2
$4.38M Buy
108,857
+21,085
+24% +$780K ﹤0.01% 2619
2014
Q1
$3.38M Buy
87,772
+7,455
+9% +$263K ﹤0.01% 2695
2013
Q4
$2.73M Sell
80,317
-5,108
-6% -$136K ﹤0.01% 2772
2013
Q3
$1.63M Sell
85,425
-13,239
-13% -$231K ﹤0.01% 2903
2013
Q2
$1.53M Buy
+98,664
New +$2.09M ﹤0.01% 2903

Other funds holding FLNA

Dimensional Fund Advisors's FLNA Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Filana Therapeutics (FLNA) stake by 71% in Q1 2026, buying an estimated $206K and bringing the position to 239,906 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

Dimensional Fund Advisors first reported a position in FLNA in Q2 2013 and has held it in 31 quarters since. The position peaked at $4.38M in Q2 2014. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Dimensional Fund Advisors held 239,906 shares of Filana Therapeutics worth $405K as of Q1 2026.
  • Dimensional Fund Advisors bought 99,849 Filana Therapeutics shares in Q1 2026, an estimated $206K.
  • Filana Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2973 holding.
  • Dimensional Fund Advisors first reported a position in Filana Therapeutics in Q2 2013 and has held it in 31 quarters since.
  • Dimensional Fund Advisors's Filana Therapeutics position peaked at $4.38M in Q2 2014.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.